CHICAGO--(BUSINESS WIRE)--CytoCore, Inc. (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced that it has entered into a five year agreement with Mundinter for distribution of the SoftPap™ Cervical Cell Collector into Portugal. Mundinter specializes in the distribution and maintenance of hospital equipment and medical products. Mundinter’s agreement calls for minimum sales of 300k units the first year, 600k units the second, 1.0mm units the third, 1.1 mm the fourth, and minimum of 1.2mm units in the fifth year.
